Cargando…

Community Use of Repurposed Drugs Before and During COVID-19 Pandemic in the Netherlands: An Interrupted Time-Series Analysis

BACKGROUND: Repurposing registered drugs could reduce coronavirus disease (COVID-19) burden before novel drugs are authorized. Little is known about how the pandemic and imposed restrictions changed their dispensing. We aimed to investigate the impact of COVID-19 pandemic on repurposed drugs dispens...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Guiling, de Vos, Stijn, Schuiling-Veninga, Catharina C M, Bos, Jens, Oude Rengerink, Katrien, Pasmooij, Anna Maria Gerdina, Mol, Peter G M, de Bock, Geertruida H, Hak, Eelko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10488695/
https://www.ncbi.nlm.nih.gov/pubmed/37694159
http://dx.doi.org/10.2147/CLEP.S418069
_version_ 1785103537176313856
author Zhou, Guiling
de Vos, Stijn
Schuiling-Veninga, Catharina C M
Bos, Jens
Oude Rengerink, Katrien
Pasmooij, Anna Maria Gerdina
Mol, Peter G M
de Bock, Geertruida H
Hak, Eelko
author_facet Zhou, Guiling
de Vos, Stijn
Schuiling-Veninga, Catharina C M
Bos, Jens
Oude Rengerink, Katrien
Pasmooij, Anna Maria Gerdina
Mol, Peter G M
de Bock, Geertruida H
Hak, Eelko
author_sort Zhou, Guiling
collection PubMed
description BACKGROUND: Repurposing registered drugs could reduce coronavirus disease (COVID-19) burden before novel drugs are authorized. Little is known about how the pandemic and imposed restrictions changed their dispensing. We aimed to investigate the impact of COVID-19 pandemic on repurposed drugs dispensing in the Netherlands. METHODS: We performed interrupted time-series study using University of Groningen prescription database IADB.nl to evaluate dispensing trends of 24 repurposed drugs before (2017-February 2020) and after (March 2020–2021) the pandemic’ start. Primary outcomes were monthly prevalence and incidence rates. An autoregressive integrated moving average model assessed the effect of pandemic and stringency index (measuring strictness of government’s restriction policies). RESULTS: Annual number of IADB.nl population ranged from 919,697 to 952,400. Generally, dispensing of common long-term-used drugs was not significantly affected by pandemic. The prevalence of antibacterials (−4.20 users per 1000 people), antivirals (−0.04), corticosteroids (−1.29), prednisolone (−1.32), calcium channel blocker (−0.41), and diuretics (−1.29) was lower than expected after the pandemic’s start, while the prevalence of ivermectin (0.07), sulfonylureas (0.15), sodium-glucose co-transporter-2 (SGLT2) inhibitor (0.17), and anticoagulants (1.95) was higher than expected. The pandemic was associated with statistically significant decreases in the incidence of antibacterials (−1.21), corticosteroids (−0.60), prednisolone (−0.64) and anticoagulants (−0.02), and increases in ivermectin (0.02), aggregated antidiabetic drugs (0.13), and SGLT2 inhibitors (0.06). These trends were positively associated with pandemic and negatively associated with stringency index. CONCLUSION: Dispensing of most drugs was not significantly associated with pandemic and government’s response. Despite some statistically significant disruptions, these were not necessarily clinically relevant due to small absolute differences observed.
format Online
Article
Text
id pubmed-10488695
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-104886952023-09-09 Community Use of Repurposed Drugs Before and During COVID-19 Pandemic in the Netherlands: An Interrupted Time-Series Analysis Zhou, Guiling de Vos, Stijn Schuiling-Veninga, Catharina C M Bos, Jens Oude Rengerink, Katrien Pasmooij, Anna Maria Gerdina Mol, Peter G M de Bock, Geertruida H Hak, Eelko Clin Epidemiol Original Research BACKGROUND: Repurposing registered drugs could reduce coronavirus disease (COVID-19) burden before novel drugs are authorized. Little is known about how the pandemic and imposed restrictions changed their dispensing. We aimed to investigate the impact of COVID-19 pandemic on repurposed drugs dispensing in the Netherlands. METHODS: We performed interrupted time-series study using University of Groningen prescription database IADB.nl to evaluate dispensing trends of 24 repurposed drugs before (2017-February 2020) and after (March 2020–2021) the pandemic’ start. Primary outcomes were monthly prevalence and incidence rates. An autoregressive integrated moving average model assessed the effect of pandemic and stringency index (measuring strictness of government’s restriction policies). RESULTS: Annual number of IADB.nl population ranged from 919,697 to 952,400. Generally, dispensing of common long-term-used drugs was not significantly affected by pandemic. The prevalence of antibacterials (−4.20 users per 1000 people), antivirals (−0.04), corticosteroids (−1.29), prednisolone (−1.32), calcium channel blocker (−0.41), and diuretics (−1.29) was lower than expected after the pandemic’s start, while the prevalence of ivermectin (0.07), sulfonylureas (0.15), sodium-glucose co-transporter-2 (SGLT2) inhibitor (0.17), and anticoagulants (1.95) was higher than expected. The pandemic was associated with statistically significant decreases in the incidence of antibacterials (−1.21), corticosteroids (−0.60), prednisolone (−0.64) and anticoagulants (−0.02), and increases in ivermectin (0.02), aggregated antidiabetic drugs (0.13), and SGLT2 inhibitors (0.06). These trends were positively associated with pandemic and negatively associated with stringency index. CONCLUSION: Dispensing of most drugs was not significantly associated with pandemic and government’s response. Despite some statistically significant disruptions, these were not necessarily clinically relevant due to small absolute differences observed. Dove 2023-09-04 /pmc/articles/PMC10488695/ /pubmed/37694159 http://dx.doi.org/10.2147/CLEP.S418069 Text en © 2023 Zhou et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Zhou, Guiling
de Vos, Stijn
Schuiling-Veninga, Catharina C M
Bos, Jens
Oude Rengerink, Katrien
Pasmooij, Anna Maria Gerdina
Mol, Peter G M
de Bock, Geertruida H
Hak, Eelko
Community Use of Repurposed Drugs Before and During COVID-19 Pandemic in the Netherlands: An Interrupted Time-Series Analysis
title Community Use of Repurposed Drugs Before and During COVID-19 Pandemic in the Netherlands: An Interrupted Time-Series Analysis
title_full Community Use of Repurposed Drugs Before and During COVID-19 Pandemic in the Netherlands: An Interrupted Time-Series Analysis
title_fullStr Community Use of Repurposed Drugs Before and During COVID-19 Pandemic in the Netherlands: An Interrupted Time-Series Analysis
title_full_unstemmed Community Use of Repurposed Drugs Before and During COVID-19 Pandemic in the Netherlands: An Interrupted Time-Series Analysis
title_short Community Use of Repurposed Drugs Before and During COVID-19 Pandemic in the Netherlands: An Interrupted Time-Series Analysis
title_sort community use of repurposed drugs before and during covid-19 pandemic in the netherlands: an interrupted time-series analysis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10488695/
https://www.ncbi.nlm.nih.gov/pubmed/37694159
http://dx.doi.org/10.2147/CLEP.S418069
work_keys_str_mv AT zhouguiling communityuseofrepurposeddrugsbeforeandduringcovid19pandemicinthenetherlandsaninterruptedtimeseriesanalysis
AT devosstijn communityuseofrepurposeddrugsbeforeandduringcovid19pandemicinthenetherlandsaninterruptedtimeseriesanalysis
AT schuilingveningacatharinacm communityuseofrepurposeddrugsbeforeandduringcovid19pandemicinthenetherlandsaninterruptedtimeseriesanalysis
AT bosjens communityuseofrepurposeddrugsbeforeandduringcovid19pandemicinthenetherlandsaninterruptedtimeseriesanalysis
AT ouderengerinkkatrien communityuseofrepurposeddrugsbeforeandduringcovid19pandemicinthenetherlandsaninterruptedtimeseriesanalysis
AT pasmooijannamariagerdina communityuseofrepurposeddrugsbeforeandduringcovid19pandemicinthenetherlandsaninterruptedtimeseriesanalysis
AT molpetergm communityuseofrepurposeddrugsbeforeandduringcovid19pandemicinthenetherlandsaninterruptedtimeseriesanalysis
AT debockgeertruidah communityuseofrepurposeddrugsbeforeandduringcovid19pandemicinthenetherlandsaninterruptedtimeseriesanalysis
AT hakeelko communityuseofrepurposeddrugsbeforeandduringcovid19pandemicinthenetherlandsaninterruptedtimeseriesanalysis